FDA Makes 'Significant Changes' To Drug Registration Rules
Executive Summary
FDA on Sept. 1 issued a final rule that requires firms to electronically submit drug registration information and clarifies who must register their establishments. The final rule goes into effect on Nov. 30, more than 10 years first proposed.
You may also be interested in...
US FDA Drops Plan To Simplify Pharmaceutical Plant Reporting
Industry complained draft guidance would have made manufacturing establishment information harder to report, not easier.
Firms That Get Complete Response Letters Might Get Inspected By US FDA Six Months After Replies
While COVID-19 continues to wreak havoc on FDA's ability to perform onsite preapproval inspections, new guidance offers some clarity, but the news isn't great for ANDA holders.
COVID-19 Spurs WHO To Revise Guidance On Technology Transfers
The WHO proposes to revise 2011 guidance on technology transfers to ease the hand-off of COVID-19 drugs and vaccines from research and development facilities to commercial sites.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: